scispace - formally typeset
Open AccessJournal ArticleDOI

Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy Significantly Upgrades Prostate Cancer Versus Systematic 12-core Transrectal Ultrasound Biopsy

Reads0
Chats0
TLDR
MRI/US-fusion-guided biopsy upgrades and detects PCa of higher Gleason score in 32% of patients compared with traditional 12-core biopsy alone, and preferentially detects higher-grade PCa while missing lower-grade tumors.
About
This article is published in European Urology.The article was published on 2013-11-01 and is currently open access. It has received 460 citations till now. The article focuses on the topics: Image-Guided Biopsy & Biopsy.

read more

Citations
More filters
Journal ArticleDOI

A comparison of magnetic resonance imaging techniques used to secure biopsies in prostate cancer patients.

TL;DR: Current imaging techniques used to secure biopsies in patients with a suspicion of PCa are reviewed and Multiparametric magnetic resonance imaging (mpMRI) and subsequent-targeted biopsy have improved the diagnostic accuracy ofPCa detection in men with an elevated or rising serum PSA.
Journal ArticleDOI

MR-targeted TRUS prostate biopsy using local reference augmentation: initial experience.

TL;DR: Tracker-based MR–TRUS fusion biopsy with local reference augmentation is feasible, especially for lesions with an MR maximum diameter of at least 10 mm or PIRADS 5 lesions, and if this is not the case, recommend in-bore MR-guided biopsy.
Journal ArticleDOI

The Future Trial: Fusion Target Biopsy of the Prostate Using Real-Time Ultrasound and MR Images. A Multicenter RCT on Target Biopsy Techniques in the Diagnosisof Prostate Cancer

TL;DR: The FUTURE trial is a three-arm randomised controlled, multicentre trial comparing three techniques of MRI targeted biopsy of the prostate amongst subjects with one prior negative TRUS biopsy and a persisting suspicion on prostate cancer.
Journal ArticleDOI

Clinical significance and predictors of oncologic outcome after radical prostatectomy for invisible prostate cancer on multiparametric MRI

TL;DR: It is found that PSA is the most clinically reliable predictor of oncologic outcome and active treatment and diagnosis should be considered for patients with iPCa with PSA > 6.2 ng/ml.
Journal ArticleDOI

Diagnosis and Monitoring of Prostatic Lesions: A Comparison of Three Modalities: Multiparametric MRI, Fusion MRI/Transrectal Ultrasound (TRUS), and Traditional TRUS.

TL;DR: To date, there have been few head-to-head trials to directly compare the use of multiparametric MRI, transrectal ultrasound, and MRI-ultrasound fusion modalities for accurate and reliable detection, active surveillance, or biopsy procedure success rates.
References
More filters
Journal ArticleDOI

Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review.

TL;DR: MRI-guided biopsy detects clinically significant prostate cancer in an equivalent number of men versus standard biopsy using fewer biopsies in fewer men, with a reduction in the diagnosis of clinically insignificant cancer.
Journal ArticleDOI

Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation.

TL;DR: Multiparametric MR imaging of the prostate at 3 T enables tumor detection, with reasonable sensitivity and specificity values, and Generalized estimating equations (GEEs) provided significant independent and additive predictive value when GEEs were used.
Related Papers (5)